Literature DB >> 17713926

Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.

Yuqi Liu1, Gillian D Henry, Rashmi S Hegde, James D Baleja.   

Abstract

The E6 protein from high-risk types of human papillomavirus (HPV) binds PDZ-domain containing proteins and targets them for degradation. We used isothermal titration calorimetry to measure the interaction of a peptide from the C-terminus of HPV-18 E6 to the second PDZ domain (PDZ2) from the human homologue of the Drosophila discs large tumor suppressor protein (hDlg). Isothermal titration calorimetry experiments with a series of peptides showed that HPV-18 E6 bound hDlg PDZ2 about 5-fold stronger than HPV-16 E6, that the contribution of Arg154 to binding was about 1 kcal/mol, and that the binding was disabled by phosphorylation at Thr156. We then used NMR to determine the solution structure of the complex of PDZ2 bound to the HPV-18 E6 peptide. The resultant structures were of high quality and had backbone root-mean-square deviations of less than 0.5 A. The structure shows a novel mode of interaction in which six residues of the HPV-18 E6 peptide are contacted by the PDZ2 domain, in contrast to the typical four residues used by class I PDZ domains. Molecular dynamics simulations supported a model in which the C- and N-terminal ends of the peptide had different mobilities within the complex. Comparison of the NMR complex structure to previously determined X-ray structures of PDZ2 by itself and bound to different peptides allows a description of conformational changes required for PDZ2 to bind to HPV-18 E6.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713926     DOI: 10.1021/bi700879k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  The plastic energy landscape of protein folding: a triangular folding mechanism with an equilibrium intermediate for a small protein domain.

Authors:  S Raza Haq; Maike C Jürgens; Celestine N Chi; Cha-San Koh; Lisa Elfström; Maria Selmer; Stefano Gianni; Per Jemth
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

2.  A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.

Authors:  Christian Kranjec; Lawrence Banks
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein.

Authors:  Hye Seon Lee; Hye-Yeoung Yun; Eun-Woo Lee; Ho-Chul Shin; Seung Jun Kim; Bonsu Ku
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

4.  Sorting of β1-adrenergic receptors is mediated by pathways that are either dependent on or independent of type I PDZ, protein kinase A (PKA), and SAP97.

Authors:  Mohammed M Nooh; Maryanne M Chumpia; Thomas B Hamilton; Suleiman W Bahouth
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

5.  Stereochemical preferences modulate affinity and selectivity among five PDZ domains that bind CFTR: comparative structural and sequence analyses.

Authors:  Jeanine F Amacher; Patrick R Cushing; Lionel Brooks; Prisca Boisguerin; Dean R Madden
Journal:  Structure       Date:  2013-11-07       Impact factor: 5.006

Review 6.  Human papilloma virus (HPV) and host cellular interactions.

Authors:  Ioannis N Mammas; George Sourvinos; Athena Giannoudis; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

7.  Determinants of stability for the E6 protein of papillomavirus type 16.

Authors:  Yuqi Liu; Jonathan J Cherry; Joseph V Dineen; Elliot J Androphy; James D Baleja
Journal:  J Mol Biol       Date:  2009-03-06       Impact factor: 5.469

8.  Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.

Authors:  André Mischo; Oliver Ohlenschläger; Peter Hortschansky; Ramadurai Ramachandran; Matthias Görlach
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

9.  SAP97 controls the trafficking and resensitization of the beta-1-adrenergic receptor through its PDZ2 and I3 domains.

Authors:  Mohammed M Nooh; Anjaparavanda P Naren; Sung-Jin Kim; Yang K Xiang; Suleiman W Bahouth
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

10.  Predicting PDZ domain mediated protein interactions from structure.

Authors:  Shirley Hui; Xiang Xing; Gary D Bader
Journal:  BMC Bioinformatics       Date:  2013-01-21       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.